No relationship between drug transporter genetic variants and tenofovir plasma concentrations or changes in glomerular filtration rate in HIV-infected adults

No relationship between drug transporter genetic variants and tenofovir plasma concentrations or changes in glomerular filtration rate in HIV-infected adults

Saved in:

Bibliographic Details
Main Authors:	Sirirungsi W., Urien S., Harrison L., Kamkon J., Tawon Y., Luekamlung N., Thongpaen S., Nilmanat A., Jourdain G., Lallemant M., Le Coeur S., Ngo-Giang-Huong N., Owen A., Cressey T.
Format:	Letter
Published:	Lippincott Williams & Wilkins Ltd. 2015
Subjects:	Pharmacology (medical) Infectious Diseases
Online Access:	http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84924508628&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38133
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	Chiang Mai University

Similar Items

Laboratory and clinical predictors of disease progression following initiation of combination therapy in HIV-infected adults in Thailand
by: Duong T., et al.
Published: (2014)

Long-term outcome of nevirapine or efavirenz based antiretroviral regimens in mothers exposed to single dose nevirapine
by: Sripan,P., et al.
Published: (2015)

Comparison of the TaqMan and LightCycler systems in evaluation of CYP2B6 516G>T polymorphism
by: Soranun Chantarangsu, et al.
Published: (2018)

Impact of HIV/aids on child mortality before the highly active antiretroviral therapy era: A study in Pointe-Noire, Republic of Congo
by: Le Coeur S., et al.
Published: (2014)

Impact of antiretroviral treatment on height evolution of HIV infected children
by: Patrinee Traisathit, et al.
Published: (2019)

Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy
by: Sripan P., et al.
Published: (2017)

Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand
by: Fregonese F., et al.
Published: (2014)

Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women
by: Soranun Chantarangsu, et al.
Published: (2018)

Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women
by: Soranun Chantarangsu, et al.
Published: (2018)

Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women
by: Soranun Chantarangsu, et al.
Published: (2018)

Perinatal zidovudine prophylaxis in HIV type-1-infected pregnant women with thalassaemia carriage in Thailand
by: Briand N., et al.
Published: (2014)

A sample size calculation of Bayesian design for superiority trials with rare events
by: Sripan P., et al.
Published: (2017)

Cost-effectiveness of early infant HIV diagnosis of HIV-exposed infants and immediate antiretroviral therapy in HIV-infected children under 24 months in Thailand
by: Collins I.J., et al.
Published: (2014)

Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand
by: Marc Lallemant, et al.
Published: (2018)

Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand
by: Marc Lallemant, et al.
Published: (2018)

Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand
by: Marc Lallemant, et al.
Published: (2018)

Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: A 5-year observational cohort study
by: Collins I.J., et al.
Published: (2014)

Correction: Modeling of In-Utero and Intra-Partum transmissions to evaluate the efficacy of interventions for the prevention of perinatal HIV
by: Patumrat Sripan, et al.
Published: (2018)

Modeling of in-utero and intra-partum transmissions to evaluate the efficacy of interventions for the prevention of perinatal HIV
by: Patumrat Sripan, et al.
Published: (2018)

Correction: Modeling of In-Utero and Intra-Partum transmissions to evaluate the efficacy of interventions for the prevention of perinatal HIV
by: Patumrat Sripan, et al.
Published: (2018)

Modeling of in-utero and intra-partum transmissions to evaluate the efficacy of interventions for the prevention of perinatal HIV
by: Patumrat Sripan, et al.
Published: (2018)

Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before Delivery
by: Marc Lallemant, et al.
Published: (2020)

Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before Delivery
by: Marc Lallemant, et al.
Published: (2020)

A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens
by: Homkham N., et al.
Published: (2017)

Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy
by: Cressey T., et al.
Published: (2017)

Impact of HIV/aids on child mortality before the highly active antiretroviral therapy era: A study in Pointe-Noire, Republic of Congo
by: Sophie Le Coeur, et al.
Published: (2018)

Laboratory and clinical predictors of disease progression following initiation of combination therapy in HIV-infected adults in Thailand
by: Trinh Duong, et al.
Published: (2018)

Incidence of tuberculosis and associated mortality in a cohort of human immunodeficiency virus-infected children initiating antiretroviral therapy
by: Salvadori N., et al.
Published: (2017)

Envelope glycoproteins of Human Immunodeficiency Virus type 1 variants issued from mother-infant pairs display a wide spectrum of biological properties
by: Thenin S., et al.
Published: (2014)

Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand
by: Ngo-Giang-Huong N., et al.
Published: (2014)

Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in Thailand
by: Federica Fregonese, et al.
Published: (2018)

Tenofovir Exposure during Pregnancy and Postpartum in Women Receiving Tenofovir Disoproxil Fumarate for the Prevention of Mother-to-Child Transmission of Hepatitis B Virus
by: Tim R. Cressey, et al.
Published: (2018)

Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand
by: Gonzague Jourdain, et al.
Published: (2018)

Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand
by: Marc Lallemant, et al.
Published: (2018)

Cost-effectiveness of early infant HIV diagnosis of HIV-exposed infants and immediate antiretroviral therapy in HIV-infected children under 24 months in Thailand
by: Intira Jeannie Collins, et al.
Published: (2018)

Cost-effectiveness of early infant HIV diagnosis of HIV-exposed infants and immediate antiretroviral therapy in HIV-infected children under 24 months in Thailand
by: Intira Jeannie Collins, et al.
Published: (2018)

Predictors of 5-years mortality in HIV-infected adults starting highly active antiretroviral therapy (HAART) in Thailand
by: Fregonese F., et al.
Published: (2014)

Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected thai patients receiving indinavir boosted with ritonavir
by: Cressey T.R., et al.
Published: (2014)

Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy
by: Patumrat Sripan, et al.
Published: (2018)

Long-term hepatitis B virus (HBV) response to Lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand
by: Khamduang W., et al.
Published: (2014)